JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 131 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $104,423 | -35.1% | 15,379 | -20.1% | 0.00% | – |
| Q4 2021 | $161,000 | +9.5% | 19,249 | -2.7% | 0.00% | – |
| Q3 2021 | $147,000 | +23.5% | 19,784 | +71.2% | 0.00% | – |
| Q1 2021 | $119,000 | +24.0% | 11,555 | -1.8% | 0.00% | – |
| Q3 2020 | $96,000 | +11.6% | 11,765 | 0.0% | 0.00% | – |
| Q2 2020 | $86,000 | +56.4% | 11,765 | +1.3% | 0.00% | – |
| Q1 2020 | $55,000 | +587.5% | 11,617 | +1055.9% | 0.00% | – |
| Q2 2018 | $8,000 | -97.0% | 1,005 | -91.5% | 0.00% | – |
| Q1 2018 | $264,000 | +64.0% | 11,829 | -6.5% | 0.00% | – |
| Q4 2017 | $161,000 | -14.8% | 12,654 | +4.1% | 0.00% | – |
| Q3 2017 | $189,000 | +9350.0% | 12,151 | +10110.9% | 0.00% | – |
| Q2 2017 | $2,000 | – | 119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 9,200,349 | $64,402,000 | 44.86% |
| TRV GP III, LLC | 3,048,780 | $21,342,000 | 1.83% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 406,665 | $2,847,000 | 1.65% |
| Sofinnova Investments, Inc. | 925,280 | $6,477,000 | 0.39% |
| Omega Fund Management, LLC | 334,965 | $2,345,000 | 0.35% |
| Yorktown Management & Research Co Inc | 49,200 | $344,000 | 0.31% |
| Woodline Partners LP | 940,902 | $6,586,000 | 0.18% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 51,000 | $357,000 | 0.09% |
| HORIZON FINANCIAL SERVICES, LLC | 12,005 | $84,000 | 0.08% |
| Gyon Technologies Capital Management, LP | 26,893 | $188,000 | 0.06% |